SENP3 is increased in the hippocampal CA1 following CCH, and chronic treatment with FAAH inhibitor decreases SENP3 and ameliorates CCH-induced NVU impairment (Wang et al., 2017). The gene discussed is SENP3; the disease is columnar cell hyperplasia of the breast.